Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|4|380-394

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.4, 2015-04, pp. : 380-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patented In Vitro Blood-Brain Barrier Models in CNS Drug Discovery

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 107-118

Bentham Science Publishers

Access to resources Recommend Favorite

Blood–brain barrier: An impediment to neuropharmaceuticals

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 308-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostics and Discovery in Viral Central Nervous System Infections

By  

BRAIN PATHOLOGY, Vol. 25, Iss. 5, 2015-09 ,pp. : 600-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brain targeting PBCA nanoparticles and the blood––brain barrier

By Wilson B  

Nanomedicine, Vol. 4, Iss. 5, 2009-07 ,pp. : 499-502

Future Medicine

Access to resources Recommend Favorite

Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)

By Kreuter Jörg  

Journal of Microencapsulation, Vol. 30, Iss. 1, 2013-02 ,pp. : 49-54

Informa Healthcare

Access to resources Recommend Favorite